Cargando…
Clinical use of anti-TNF therapy and increased risk of infections
Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important agents in the treatment of many chronic inflammatory diseases, especially in cases refractory to conventional treatment modalities. However, opportunistic infections have become a major safety concern in patients...
Autores principales: | Ali, Tauseef, Kaitha, Sindhu, Mahmood, Sultan, Ftesi, Abdul, Stone, Jordan, Bronze, Michael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3615849/ https://www.ncbi.nlm.nih.gov/pubmed/23569399 http://dx.doi.org/10.2147/DHPS.S28801 |
Ejemplares similares
-
Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease
por: Thanou, Aikaterini, et al.
Publicado: (2013) -
Corrigendum to “Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease”
por: Thanou, Aikaterini, et al.
Publicado: (2017) -
Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritis
por: Chen, Ying-Chou, et al.
Publicado: (2017) -
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis
por: Gregory, Adam P., et al.
Publicado: (2012) -
Screening for tuberculosis infection prior to initiation of anti-TNF therapy
por: Lalvani, Ajit, et al.
Publicado: (2008)